Arie Belldegrun is the co-chairman of Symbiotic Capital, a $600 million life sciences credit firm affiliated with Bellco Capital. See contact routes.
Arie Belldegrun is the co-chairman of Symbiotic Capital, a $600 million life sciences credit firm affiliated with Bellco Capital, the private equity company he co-founded with his wife. As an angel investor and venture co-founder of Vida Ventures, he targets later-stage life science companies across drug development, medical technologies, diagnostics, and healthcare IT, primarily in the United States. His typical angel check ranges from $100,000 to $10 million with a sweet spot around $1 million, often acting as a follow investor rather than a lead. Notable portfolio companies include Kronos Bio, Entera Bio, and Kite Pharma, all within biotechnology and drug delivery sectors. Belldegrun distinguishes his credit approach by offering non-dilutive senior secure term loans structured to allow conversion into equity, specifically designed for biotech firms years away from stable revenue. He is an Israeli-American urologic oncologist and billionaire entrepreneur who sold Kite Pharma to Gilead Sciences for $11.9 billion before launching his investment firms.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Los Angeles.
Investors like Arie Belldegrun · Full investor directory · Investor access · Company funding database